Literature DB >> 15928378

Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis.

Mona Waterhouse1, Claire Wilson, Veronica L C White, Tahseen A Chowdhury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15928378      PMCID： PMC1142232          DOI： 10.1177/014107680509800607

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  10 in total

1.  Interaction of gliclazide and rifampicin.

Authors:  Y Kihara; M Otsuki
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Metabolic effects of treatment with atypical antipsychotics.

Authors:  John M Kane; Eugene J Barrett; Daniel E Casey; Christoph U Correll; Alan J Gelenberg; Samuel Klein; John W Newcomer
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

3.  Interaction of rifampin and glyburide.

Authors:  T H Self; S J Tsiu; J W Fowler
Journal:  Chest       Date:  1989-12       Impact factor: 9.410

4.  The oral glucose tolerance test in patients with respiratory infections.

Authors:  O K Başoğlu; F Bacakoğlu; G Cok; A Sayiner; M Ateş
Journal:  Monaldi Arch Chest Dis       Date:  1999-08

Review 5.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

6.  Increased insulin requirement in a patient with type 1 diabetes on rifampicin.

Authors:  S L Atkin; E A Masson; C W Bodmer; B A Walker; M C White
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

7.  Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.

Authors:  Hans J Woerle; Peter R Mariuz; Christian Meyer; Richard C Reichman; Emilia M Popa; Jean M Dostou; Stephen L Welle; John E Gerich
Journal:  Diabetes       Date:  2003-04       Impact factor: 9.461

8.  Pulmonary tuberculosis--a review of clinical features and diagnosis in 232 cases.

Authors:  Y Ismail
Journal:  Med J Malaysia       Date:  2004-03

9.  Tuberculosis and diabetes in southern Mexico.

Authors:  Alfredo Ponce-De-Leon; Ma de Lourdes Garcia-Garcia Md; Ma Cecilia Garcia-Sancho; Francisco J Gomez-Perez; Jose Luis Valdespino-Gomez; Gustavo Olaiz-Fernandez; Rosalba Rojas; Leticia Ferreyra-Reyes; Bulmaro Cano-Arellano; Miriam Bobadilla; Peter M Small; Jose Sifuentes-Osornio
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

10.  Rifampicin-induced early phase hyperglycemia in humans.

Authors:  N Takasu; T Yamada; H Miura; S Sakamoto; M Korenaga; K Nakajima; M Kanayama
Journal:  Am Rev Respir Dis       Date:  1982-01
  10 in total
  6 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.

Authors:  Lindsey H M Te Brake; Jeroen J M W van den Heuvel; Aaron O Buaben; Reinout van Crevel; Albert Bilos; Frans G Russel; Rob E Aarnoutse; Jan B Koenderink
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Differentiating transient from persistent diabetic range hyperglycemia in a cohort of people completing tuberculosis treatment in Dhaka, Bangladesh.

Authors:  Yosra M A Alkabab; Samanta Biswas; Shahriar Ahmed; Kishor Paul; Jyothi Nagajyothi; Sayera Banu; Scott Heysell
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

4.  Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.

Authors:  Lindsey H M Te Brake; Vycke Yunivita; Resvi Livia; Nanny Soetedjo; Eleonora van Ewijk-Beneken Kolmer; Jan B Koenderink; David M Burger; Prayudi Santoso; Reinout van Crevel; Bachti Alisjahbana; Rob E Aarnoutse; Rovina Ruslami
Journal:  Clin Pharmacol Ther       Date:  2018-10-29       Impact factor: 6.875

5.  Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.

Authors:  Charles M Mtabho; Hadija H Semvua; Jossy van den Boogaard; Constantine F Irongo; Martin J Boeree; Angela Colbers; David M Burger; Reinout van Crevel; Andre J A M van der Ven; Gibson S Kibiki; Alma Tostmann; Rob E Aarnoutse
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790

6.  Diabetes mellitus and tuberculosis facts and controversies.

Authors:  Parvaneh Baghaei; Majid Marjani; Pedram Javanmard; Payam Tabarsi; Mohammad Reza Masjedi
Journal:  J Diabetes Metab Disord       Date:  2013-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.